Patent: 8,962,804
✉ Email this page to a colleague
Summary for Patent: 8,962,804
Title: | Meditopes and meditope-binding antibodies and uses thereof |
Abstract: | Antibodies and meditopes that bind to the antibodies are provided, as well as complexes, compositions and combinations containing the meditopes and antibodies, and methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses. |
Inventor(s): | Williams; John C. (Monrovia, CA), Horne; David A. (Duarte, CA), Ma; Yuelong (Duarte, CA), Chang; Heng Wei (Foster City, CA), Donaldson; Joshua Michael (Lumberton, NJ), Zer; Cindy (Duarte, CA), Bzymek; Krzysztof (Pasadena, CA), Avery; Kendra Nicole (Pasadena, CA), Xie; Jun (Duarte, CA) |
Assignee: | City of Hope (Duarte, CA) |
Application Number: | 13/443,804 |
Patent Claims: | see list of patent claims |
Details for Patent 8,962,804
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Centocor Ortho Biotech Products, L.p. | ORTHOCLONE OKT3 | muromanab-cd3 | Injection | 103463 | 09/14/1992 | ⤷ Try a Trial | 2030-10-08 |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 12/22/1994 | ⤷ Try a Trial | 2030-10-08 |
Aytu Bioscience, Inc. | PROSTASCINT | capromab pendetide | Injection | 103608 | 10/28/1996 | ⤷ Try a Trial | 2030-10-08 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2030-10-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |